HR5435Referred to Committee

Stop CMV Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-09-17
Introduced
11
Cosponsors
HR
ⓘ
Type

Sponsor

Michael Lawler
Michael Lawler
Republican · NY · Representative
Votes with party: 92.5% (544 recorded votes)

Full profile: /officials/L000599

Source: Congress.gov · FEC

Cosponsors (11)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2025-09-17

Source: Congress.gov

Plain-English Summary

This bill aims to address cytomegalovirus (CMV), a common virus that can cause serious complications in newborns and people with weakened immune systems, though the specific measures are not detailed in the current status. The legislation likely focuses on prevention, treatment, or research efforts related to CMV infections that affect vulnerable populations like infants and immunocompromised patients. Once referred to the House Committee on Energy and Commerce, the bill will be reviewed for its potential impact on public health policy and medical care.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.